Skip to content

Adecoagro

US · AGRO #2956 by market cap Listed 1970
10.48 -0.34 -3.14%
Live - 5344 symbols - heartbeat 207s ago · 2026-10-08 04:45
Pre-market 10.90 +4.01%
After-hours 10.48 0.00%
Overnight 10.45 -0.29%
Market cap
1.51B
P/B
0.87
EPS
-0.08
Reader sentiment Are you bullish or bearish on AGRO?

Anonymous reader poll. Unscientific, not investment advice.

Valuation each multiple against its own 5-year range

P/B ratio 0.90 In line with history 63rd percentile
5-year average 0.87 · #4 of 19 in Farm Products
P/E ratio 34.03 Expensive vs history 89th percentile
5-year average 34.60 · forward 8.15 · #8 of 11 in Farm Products
P/S ratio 0.95 Expensive vs history 83rd percentile
5-year average 0.78 · forward 0.70 · #16 of 25 in Farm Products

Vs. peers Farm Products

Company Market cap P/E (TTM) P/B Div yield
Adecoagro (AGRO) 1.51B 32.96 0.87 2.82%
Archer Daniels Midland (ADM) 39.20B 22.22 1.66 2.53%
Bunge (BG) 20.27B 22.84 1.27 2.67%
Tyson Foods (TSN) 18.19B 31.91 1.01 3.93%
Smithfield Foods (SFD) 7.28B 6.88 1.04 6.08%
Cal-Maine Foods (CALM) 2.93B 50.16 1.14 3.91%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value14.10 Economic moatNone UncertaintyHigh

Trading 34.5% below Morningstar's fair value estimate.

Fair value

Adecoagro SA may seem undervalued at first glance, due to its considerable price decline over the past year. However, to account for the risk associated with a potential value trap, we have limited its rating to 3 stars. The stock currently trades at a 23% discount to our quantitative fair value estimate of $14.10 per share; however, caution is warranted due to this estimate's high uncertainty rating.

The company's valuation metrics bolster our estimated fair value. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 118.5%, which lies in the top 30% compared with peers globally. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are cheap.

The company's balance sheet is an additional encouraging factor. Leverage can enable a company to invest in growth, potentially boosting shareholder value more than equity financing alone. The firm's EBITDA/interest coverage ratio of 2.5, for example, falls in the bottom 30% compared with global peers. Although the firm's ability to cover interest payments with EBITDA is limited, shares could sharply rebound if economic circumstances change or recent investments reduce fears of default. This characteristic further promotes our favorable price/fair value ratio.

Economic moat

With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-10-08 04:45:16 · For reference only, not investment advice and not tailored to your situation.